FDA Acts to Avoid Shortage and Strengthen the Safety of
FDA Acts to Avoid Shortage and Strengthen the Safety of Sucraid
The U.S. Food and Drug Administration today issued an expedited approval of a supplemental application that allows for changes in the manufacturing of Sucraid (sacrosidase) Oral Solution.